Markers for bacterial infection in children with fever without source

Archives of Disease in Childhood

Volumn 96, Issue 5, 2011, Pages 440-446

  Manzano, Sergio ^a,b   Bailey, Benoit ^a   Gervaix, Alain ^b   Cousineau, Jocelyne ^c   Delvin, Edgar ^c   Girodias, Jean Bernard ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Children's Hospital HUG   (Switzerland)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

AREA UNDER THE CURVE; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BLOOD CULTURE; CLINICAL EVALUATION; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; FEVER; HUMAN; INFANT; INFANT DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NEUTROPHIL COUNT; PNEUMONIA; PRIORITY JOURNAL; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE; VISUAL ANALOG SCALE;

EID: 79954590099     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2010.203760     Document Type: Article

References (38)

1. Black S, Shinefield H, Baxter R, et al. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J 2004;23:485-9. (Pubitemid 38802290)
2. Herz AM, Greenhow TL, Alcantara J, et al. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine. Pediatr Infect Dis J 2006;25:293-300.
3. Girodias JB, Bailey B. Approach to the febrile child: A challenge bridging the gap between the literature and clinical practice. Paediatr Child Health 2003;8:76-82. (Pubitemid 36514346)
4. Andreola B, Bressan S, Callegaro S, et al. P rocalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department. Pediatr Infect Dis J 2007;26:672-7. (Pubitemid 47424634)
5. Bonsu BK, Chb M, Harper MB. Identifying febrile young infants with bacteremia: is the peripheral white blood cell count an accurate screen? Ann Emerg Med 2003;42:216-25.
6. Fernández Lopez A, Luaces Cubells C, García García JJ, et al. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker. Pediatr Infect Dis J 2003;22:895-903. (Pubitemid 37288613)
7. Galetto-Lacour A, Zamora SA, Gervaix A. Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics 2003;112:1054-60. (Pubitemid 37339556)
8. Mintegi S, Benito J, Sanchez J, et al. Predictors of occult bacteremia in young febrile children in the era of heptavalent pneumococcal conjugated vaccine. Eur J Emerg Med 2009;16:199-205.
9. Gendrel D, Raymond J, Coste J, et al. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections. Pediatr Infect Dis J 1999;18:875-81. (Pubitemid 29487507)
10. Lacour AG, Gervaix A, Zamora SA, et al. Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs. Eur J Pediatr 2001;160:95-100. (Pubitemid 32204534)
11. Thayyil S, Shenoy M, Hamaluba M, et al. Is procalcitonin useful in early diagnosis of serious bacterial infections in children? Acta Paediatr 2005;94:155-8.
12. Manzano S, Bailey B, Girodias JB, et al. Impact of procalcitonin on the management of children aged 1 to 36 months presenting with fever without source: a randomized controlled trial. Am J Emerg Med 2010;28:647-53.
13. Boulianne N, Bradet R, Audet D, et al. Enquete sur la couverture vaccinale des enfants de 1 an et 2 ans au Quebec en 2008. Institut National de Sante Publique du Quebec. http://www.inspq.qc.ca/pdf/publications/1045- CouverturVaccinEnfants1et2Ans2008.pdf (accessed 22 December 2010).
14. Wals PD, Carbon M, Sévin E, et al. Reduced physician claims for otitis media after implementation of pneumococcal conjugate vaccine program in the province of Quebec, Canada. Pediatr Infect Dis J 2009;28:e271-5.
15. Fagan TJ. Letter: Nomogram for Bayes theorem. N Engl J Med 1975;293:257.
16. Fischer JE, Bachmann LM, Jaeschke R. A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med 2003;29:1043-51.
17. Baraff LJ, Bass JW, Fleisher GR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. Ann Emerg Med 1993;22:1198-210. (Pubitemid 23191038)
18. Isaacman DJ, Burke BL. Utility of the serum C-reactive protein for detection of occult bacterial infection in children. Arch Pediatr Adolesc Med 2002;156:905-9. (Pubitemid 36343502)
19. Pulliam PN, Attia MW, Cronan KM. C-reactive protein in febrile children 1 to 36 months of age with clinically undetectable serious bacterial infection. Pediatrics 2001;108:1275-9. (Pubitemid 33121468)
20. Baker MD, Avner JR, Bell LM. Failure of infant observation scales in detecting serious illness in febrile, 4- to 8-week-old infants. Pediatrics 1990;85:1040-3.
21. Baskin MN, O'Rourke EJ, Fleisher GR. Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriaxone. J Pediatr 1992;120:22-7.
22. American College of Emergency Physicians Clinical Policies Committee. Clinical policy for children younger than three years presenting to the emergency department with fever. Ann Emerg Med 2003;42:530-45.
23. Pratt A, Attia MW. Duration of fever and markers of serious bacterial infection in young febrile children. Pediatr Int 2007;49:31-5. (Pubitemid 46146681)
24. Bilavsky E, Yarden-Bilavsky H, Ashkenazi S, et al. C-reactive protein as a marker of serious bacterial infections in hospitalized febrile infants. Acta Paediatr 2009;98:1776-80.
25. Rudinsky SL, Carstairs KL, Reardon JM, et al. Serious bacterial infections in febrile infants in the post-pneumococcal conjugate vaccine era. Acad Emerg Med 2009;16:585-90.
26. Hatherill M, Tibby SM, Sykes K, et al. Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leucocyte count. Arch Dis Child 1999;81:417-21. (Pubitemid 29501374)
27. Benito-Fernández J, Raso SM, Pocheville-Gurutzeta I, et al. Pneumococcal bacteremia among infants with fever without known source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain. Pediatr Infect Dis J 2007;26:667-71. (Pubitemid 47424633)
28. Wilkinson M, Bulloch B, Smith M. Prevalence of occult bacteremia in children aged 3 to 36 months presenting to the emergency department with fever in the postpneumococcal conjugate vaccine era. Acad Emerg Med 2009;16:220-5.
29. Lee GM, Fleisher GR, Harper MB. Management of febrile children in the age of the conjugate pneumococcal vaccine: a cost-effectiveness analysis. Pediatrics 2001;108:835-44. (Pubitemid 32947650)
30. Stoll ML, Rubin LG. Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine: a study from a Children's Hospital Emergency Department and Urgent Care Center. Arch Pediatr Adolesc Med 2004;158:671-5. (Pubitemid 38886493)
31. Alpern ER, Alessandrini EA, Bell LM, et al. Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome. Pediatrics 2000;106:505-11. (Pubitemid 30664136)
32. Gómez B, Mintegi S, Benito J, et al. Blood culture and bacteremia predictors in infants less than three months of age with fever without source. Pediatr Infect Dis J 2010;29:43-7.
33. Benador N, Siegrist CA, Gendrel D, et al. Procalcitonin is a marker of severity of renal lesions in pyelonephritis. Pediatrics 1998;102:1422-5. (Pubitemid 28550836)
34. Güven AG, Kazdal HZ, Koyun M, et al. Accurate diagnosis of acute pyelonephritis: How helpful is procalcitonin? Nucl Med Commun 2006;27:715-21.
35. Tuerlinckx D, Vander Borght T, Glupczynski Y, et al. Is procalcitonin a good marker of renal lesion in febrile urinary tract infection? Eur J Pediatr 2005;164:651-2.
36. Courtoy I, Lande AE, Turner RB. Accuracy of radiographic differentiation of bacterial from nonbacterial pneumonia. Clin Pediatr (Phila) 1989;28:261-4. (Pubitemid 19159173)
37. Isaacs D. Problems in determining the etiology of community-acquired childhood pneumonia. Pediatr Infect Dis J 1989;8:143-8. (Pubitemid 19077616)
38. Korppi M, Kiekara O, Heiskanen-Kosma T, et al. Comparison of radiological findings and microbial aetiology of childhood pneumonia. Acta Paediatr 1993;82:360-3. (Pubitemid 23142850)